title: Preparation of the phycoerythrin subunit liposome in a photodynamic experiment on liver cancer cells.
abstract: OBJECTIVE
  Efforts are underway to establish a preparation method for the phycoerythrin subunit (PE-sub) liposome, and enhance the cellular uptake and photodynamic therapy (PDT) effect on cancer cells.
  
  
  METHODS
  A film dispersion method was used to prepare the PE-sub liposome, an orthogonal analysis was conducted to optimize the PE-sub liposome preparation condition and determine the effects of liposomes as carriers on cell uptake in vitro. Under a fluorescence microscope, the cell survival rate of normal liver cell line HL7702 and liver cancer cell line HepG2 was assessed by 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide assay. Cell apoptosis was determined with flow cytometry and acridine orange staining after PDT treatment.
  
  
  RESULTS
  The optimum preparation conditions of the PE-sub liposome were found: a phosphatidylcholine-to-cholesterin ratio of 1:2, a PE-sub-to-lipid ratio of 1:30, 20 mL buffer volume, 10 min sonication time, and an average encapsulation rate of up to 47.2%. The particle size ranged from 80 to 200 nm, and the average particle diameter was 136 nm. At a concentration of 100 microg/mL, the transfection rate of the PE-sub liposome reached 18% at 2 h and 24% at 4 h, and remained steady at 5-6 h. The half lethal dose of PDT on HepG2 was 75 microg/mL, whereas the cell survival rate of HL7702 reached 80% at the same dosage. The PDT-treated cells showed characteristics of apoptosis.
  
  
  CONCLUSIONS
  The film dispersion method was found to maintain the biological characteristics of the PE-sub. The use of the liposome carrier increased the PE-sub accumulation in the cells and enhanced its PDT effect on HepG2 compared to the PE-sub. HL7702 cell toxicity on had less apparent change after PDT treatment. The PE-sub liposome demonstrated good tumor-targeting characteristics in the in vitro experiment.
authors.affiliation: School of Life Science, Anhui University, Hefei 230039, China.
authors.forename: Ling
authors.initials: L
authors.lastname: Hu
authors.forename: Bei
authors.initials: B
authors.lastname: Huang
authors.forename: Man-man
authors.initials: MM
authors.lastname: Zuo
authors.forename: Rui-yong
authors.initials: RY
authors.lastname: Guo
authors.forename: Hao
authors.initials: H
authors.lastname: Wei
mesh_terms: D045744:Cell Line, Tumor; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D008081:Liposomes / Q000737:chemistry*; D008113:Liver Neoplasms / Q000628:therapy*; D010316:Particle Size; D010778:Photochemotherapy / Q000379:methods; D010799:Phycoerythrin / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D021122:Protein Subunits / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D021122:Protein Subunits; D010799:Phycoerythrin